HER2+ BC: Residual Disease After Neoadjuvant Therapy
EP. 1: Case Review: T-DM1 for Residual HER2+ Breast Cancer
May 23rd 2019
EP. 2: Improving Long-Term Outcomes in HER2+ Breast Cancer
May 23rd 2019
EP. 3: Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC
May 23rd 2019
EP. 4: HER2+ Breast Cancer: Managing Patients on T-DM1
May 23rd 2019
